MedPath
NMPA Approval

Cabotegravir Sodium Tablets

国药准字HJ20230094

July 11, 2023

Drug Information

卡替拉韦钠片

万凯锐

片剂

30mg(按C₁₉H₁₇F₂N₃O₅计)

化学药品

July 11, 2023

July 10, 2028

Company Information

Applicant Company

ViiV Healthcare BV

Van Asch van Wijckstraat 55H, 3811 LP Amersfoort, Netherlands

Manufacturing Company

glaxo operations uk ltd (trading as glaxo wellcome operations)

Priory Street, Hertfordshire, SG12 0DJ, Ware, United Kingdom

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.

卡替拉韦钠片 - NMPA 批准文号 | MedPath